Proteases and receptors in the recruitment of endothelial progenitor cells in neovascularization

European Cytokine Network

Volumn 20, Issue 4, 2009, Pages 207-219

  Verloop, Robert E ^a   Koolwijk, Pieter ^a   Van Zonneveld, Anton Jan ^b   Van Hinsbergh, Victor W M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; ECFC; Endothelial colony forming cell; EPC; Matrix metalloproteinase; Urokinase

Indexed keywords

ADAM PROTEIN; CATHEPSIN L; CD34 ANTIGEN; CYTOKINE; MATRIX METALLOPROTEINASE; PROTEINASE; RECEPTOR; SERINE PROTEINASE; UROKINASE;

ANGIOGENESIS; BLOOD VESSEL; BONE MARROW; CD34 SELECTION; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL HOMING; CELL MOTILITY; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CHEMOTAXIS; COLONY FORMING UNIT; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TISSUE ENGINEERING; TUMOR VASCULARIZATION;

ANIMALS; CELL MOVEMENT; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE HYDROLASES; RECEPTORS, CELL SURFACE; STEM CELLS;

EID: 72249115656     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2009.0174     Document Type: Review

References (134)

1. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964. (Pubitemid 27087709)
2. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249.
3. Werner N, Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arteriosclerosis, thrombosis, and vascular biology 2006; 26: 257. (Pubitemid 43732183)
4. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008; 197: 496.
5. Peters BA, Diaz LA, Polyak K, et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nature medicine 2005; 11: 261. (Pubitemid 40460552)
6. De Palma M, Venneri MA, Roca C, Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nature medicine 2003; 9: 789. (Pubitemid 36749231)
7. Purhonen S, Palm J, Rossi D, et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proceedings of the National Academy of Sciences of the United States of America 2008; 105: 6620. (Pubitemid 351754556)
8. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. The Journal of clinical investigation 2000; 105(1): 71. (Pubitemid 30036389)
9. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arteriosclerosis, thrombosis, and vascular biology 2008; 28: 1584.
10. Fina L, Molgaard HV, Robertson D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood 1990; 75: 2417. (Pubitemid 20202322)
11. Ito H, Rovira II, Bloom ML, et al. Endothelial progenitor cells as putative targets for angiostatin. Cancer research 1999; 59: 5875. (Pubitemid 30004942)
12. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. The New England journal of medicine 2003; 348: 593. (Pubitemid 36204953)
13. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circulation research 2001; 89: E1.
14. Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 103: 2885. (Pubitemid 32578123)
15. Yoder MC, Mead LE, Prater D, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109: 1801. (Pubitemid 46348173)
16. Rohde E, Malischnik C, Thaler D, et al. Blood monocytes mimic endothelial progenitor cells. Stem cells (Dayton, Ohio) 2006; 24: 357. (Pubitemid 44464805)
17. Rohde E, Bartmann C, Schallmoser K, et al. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem cells (Dayton, Ohio) 2007; 25: 1746. (Pubitemid 47121853)
18. van Beem RT, Noort WA, Voermans C, et al. The presence of activated CD4(+) T cells is essential for the formation of colony-forming unit-endothelial cells by CD14(+) cells. J Immunol 2008; 180: 5141.
19. Hur J, Yang HM, Yoon CH, et al. Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. Circulation 2007; 116: 1671. (Pubitemid 47537841)
20. Prokopi M, Pula G, Mayr U, et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 2009; 114: 723.
21. De Palma M, Venneri MA, Galli R, et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer cell 2005; 8: 211. (Pubitemid 41317592)
22. O'Neill TJt. Wamhoff BR, Owens GK, Skalak TC. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circulation research 2005; 97: 1027.
23. Zentilin L, Tafuro S, Zacchigna S, et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 2006; 107: 3546.
24. Grunewald M, Avraham I, Dor Y, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006; 124: 175. (Pubitemid 43069318)
25. Okamoto R, Ueno M, Yamada Y, et al. Hematopoietic cells regulate the angiogenic switch during tumorigenesis. Blood 2005; 105: 2757. (Pubitemid 40446266)
26. Rafii S, Lyden D. Cancer. A few to flip the angiogenic switch. Science 2008; 319: 163.
27. Anghelina M, Krishnan P, Moldovan L, Moldovan NI. Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles. The American journal of pathology 2006; 168: 529. (Pubitemid 43271151)
28. Moldovan NI, Goldschmidt-Clermont PJ, Parker-Thornburg J, Shapiro SD, Kolattukudy PE. Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circulation research 2000; 87: 378. (Pubitemid 30688987)
29. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164.
30. Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arteriosclerosis, thrombosis, and vascular biology 2004; 24: 288. (Pubitemid 38197580)
31. Rookmaaker MB, Verhaar MC, Loomans CJ, et al. CD34+ cells home, proliferate, and participate in capillary formation, and in combination with CD34- cells enhance tube formation in a 3-dimensional matrix. Arteriosclerosis, thrombosis, and vascular biology 2005; 25: 1843.
32. Gulati R, Jevremovic D, Peterson TE, et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circulation research 2003; 93: 1023. (Pubitemid 37485031)
33. Ishikawa M, Asahara T. Endothelial progenitor cell culture for vascular regeneration. Stem cells and development 2004; 13: 344. (Pubitemid 39223284)
34. Melero-Martin JM, Khan ZA, Picard A, Wu X, Paruchuri S, Bischoff J. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 2007; 109: 4761.
35. Shepherd BR, Enis DR,Wang F, Suarez Y, Pober JS, Schechner JS. Vascularization and engraftment of a human skin substitute using circulating progenitor cell-derived endothelial cells. Faseb J 2006; 20: 1739.
36. Yoon CH, Hur J, Park KW, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005; 112: 1618. (Pubitemid 41324524)
37. Case J, Mead LE, Bessler WK, et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Experimental hematology 2007; 35: 1109.
38. Timmermans F, Van Hauwermeiren F, De Smedt M, et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arteriosclerosis, thrombosis, and vascular biology 2007; 27: 1572. (Pubitemid 46986112)
39. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circulation research 2004; 95: 343. (Pubitemid 39100452)
40. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nature medicine 2003; 9: 702. (Pubitemid 36749219)
41. Khakoo AY, Finkel T. Endothelial progenitor cells. Annual review of medicine 2005; 56: 79.
42. Hristov M, Weber C. The therapeutic potential of progenitor cells in ischemic heart disease-Past, present and future. Basic research in cardiology 2006; 101: 1. (Pubitemid 43323426)
43. Hristov M, Fach C, Becker C, et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 2007; 192: 413. (Pubitemid 46726323)
44. Piaggio G, Rosti V, Corselli M, et al. Endothelial colony forming cells (ECFCs) from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker. Blood 2009; in press.
45. Levesque JP, Winkler IG, Hendy J, et al. Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow. Stem cells (Dayton, Ohio) 2007; 25: 1954. (Pubitemid 47258173)
46. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841.
47. Kiel MJ, Morrison SJ. Uncertainty in the niches that maintain haematopoietic stem cells. Nature reviews 2008; 8: 290.
48. Blank U, Karlsson G, Karlsson S. Signaling pathways governing stem-cell fate. Blood 2008; 111: 492.
49. Arai F, Suda T. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Annals of the New York Academy of Sciences 2007; 1106: 41. (Pubitemid 47443041)
50. van Hinsbergh VWM, Koolwijk P. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovascular research 2008; 78: 203. (Pubitemid 351556093)
51. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109: 625. (Pubitemid 34628725)
52. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701. (Pubitemid 32290358)
53. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952. (Pubitemid 30062717)
54. Aicher A, Heeschen C, Mildner-Rihm C, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nature medicine 2003; 9: 1370. (Pubitemid 37466185)
55. McCarthy SM, Bove PF, Matthews DE, Akaike T, van der Vliet A. Nitric oxide regulation of MMP-9 activation and its relationship to modifications of the cysteine switch. Biochemistry 2008; 47: 5832. (Pubitemid 351747062)
56. Sasaki K, Heeschen C, Aicher A, et al. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proceedings of the National Academy of Sciences of the United States of America 2006; 103: 14537. (Pubitemid 44484785)
57. Trop S, Tremblay ML, Bourdeau A. Modulation of bone marrow-derived endothelial progenitor cell activity by protein tyrosine phosphatases. Trends in cardiovascular medicine 2008; 18: 180.
58. Levesque JP, Liu F, Simmons PJ, et al. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood 2004; 104: 65. (Pubitemid 38879839)
59. Winkler IG, Levesque JP. Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone. Experimental hematology 2006; 34: 996.
60. Hristov M, Weber C. Ambivalence of progenitor cells in vascular repair and plaque stability. Current opinion in lipidology 2008; 19: 491.
61. Wang CH, Verma S, Hsieh IC, et al. Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. Journal of molecular and cellular cardiology 2006; 41: 34. (Pubitemid 43946959)
62. Christopherson 2nd KW, Uralil SE, Porecha NK, Zabriskie RC, Kidd SM, Ramin SM. G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38- human cord blood hematopoietic cells. Experimental hematology 2006; 34: 1060.
63. Selleri C, Montuori N, Ricci P, et al. Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood 2005; 105: 2198. (Pubitemid 40731813)
64. Selleri C, Montuori N, Ricci P, et al. In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer. Cancer research 2006; 66: 10885.
65. Tjwa M, Sidenius N, Moura R, et al. Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells. The Journal of clinical investigation 2009; 119: 1008.
66. Xu J, Liu X, Chen J, et al. Simvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathway. Am J Physiol Cell Physiol 2009; 296: C535.
67. Xu J, Liu X, Jiang Y, et al. MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell. Journal of cellular and molecular medicine 2008; 12: 2395.
68. Kleinman ME, Greives MR, Churgin SS, et al. Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arteriosclerosis, thrombosis, and vascular biology 2007; 27: 2664.
69. Hur J, Yoon CH, Lee CS, et al. Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle. Stem cells (Dayton, Ohio) 2007; 25: 1769. (Pubitemid 47121856)
70. Maeng YS, Choi HJ, Kwon JY, et al. Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLC{beta}2 axis. Blood 2009; 113: 233.
71. Fujiyama S, Amano K, Uehira K, et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circulation research 2003; 93: 980. (Pubitemid 37433236)
72. Liehn EA, Schober A, Weber C. Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in ApoE-deficient mice. Arteriosclerosis, thrombosis, and vascular biology 2004; 24: 1891. (Pubitemid 39350309)
73. Hristov M, Zernecke A, Bidzhekov K, et al. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circulation research 2007; 100: 590. (Pubitemid 46673269)
74. Krankel N, Katare RG, Siragusa M, et al. Role of Kinin B2 Receptor Signaling in the Recruitment of Circulating Progenitor Cells With Neovascularization Potential. Circulation research 2008; 103: 1335.
75. Bernhagen J, Krohn R, Lue H, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nature medicine 2007; 13: 587. (Pubitemid 46828480)
76. Kollet O, Shivtiel S, Chen YQ, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. The Journal of clinical investigation 2003; 112: 160. (Pubitemid 38056352)
77. Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362: 697. (Pubitemid 37101067)
78. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005; 106: 1901.
79. Becchi C, Pillozzi S, Fabbri LP, et al. The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis. International journal of immunopathology and pharmacology 2008; 21: 697.
80. Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends in immunology 2007; 28: 299. (Pubitemid 46963141)
81. Massberg S, Konrad I, Schurzinger K, et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. The Journal of experimental medicine 2006; 203: 1221. (Pubitemid 43736592)
82. Tan Y, Shao H, Eton D, et al. Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor. Cardiovascular research 2007; 73: 823. (Pubitemid 46227354)
83. Zernecke A, Schober A, Bot I, et al. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circulation research 2005; 96: 784. (Pubitemid 40559518)
84. Damas JK, Waehre T, Yndestad A, et al. Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation 2002; 106: 36. (Pubitemid 34747439)
85. Liu ZJ, Velazquez OC. Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxidants & redox signaling 2008; 10: 1869.
86. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature medicine 2004; 10: 858.
87. Karshovska E, Zernecke A, Sevilmis G, et al. Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice. Arteriosclerosis, thrombosis, and vascular biology 2007; 27: 2540. (Pubitemid 350158903)
88. Koolwijk P, van Erck MG, de Vree WJ, et al. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. The Journal of cell biology 1996; 132: 1177. (Pubitemid 3039145)
89. Vajkoczy P, Blum S, Lamparter M, et al. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. The Journal of experimental medicine 2003; 197: 1755. (Pubitemid 36745350)
90. Oh IY, Yoon CH, Hur J, et al. Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood 2007; 110: 3891. (Pubitemid 350248444)
91. Foubert P, Silvestre JS, Souttou B, et al. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells. The Journal of clinical investigation 2007; 117: 1527. (Pubitemid 46871337)
92. de Boer HC, Verseyden C, Ulfman LH, et al. Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype. Arteriosclerosis, thrombosis, and vascular biology 2006; 26: 1653. (Pubitemid 44288997)
93. Chavakis E, Aicher A, Heeschen C, et al. Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. The Journal of experimental medicine 2005; 201: 63. (Pubitemid 40130084)
94. Jin H, Aiyer A, Su J, et al. A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. The Journal of clinical investigation 2006; 116: 652. (Pubitemid 43326874)
95. Qin G, Ii M, Silver M, et al. Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. The Journal of experimental medicine 2006; 203: 153. (Pubitemid 43139654)
96. Duan H, Cheng L, Sun X, et al. LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue. Thrombosis and haemostasis 2006; 96: 807. (Pubitemid 44883823)
97. Yoon CH, Hur J, Oh IY, et al. Intercellular adhesion molecule-1 is upregulated in ischemic muscle, which mediates trafficking of endothelial progenitor cells. Arteriosclerosis, thrombosis, and vascular biology 2006; 26: 1066. (Pubitemid 43732113)
98. Daub K, Langer H, Seizer P, et al. Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells. Faseb J 2006; 20: 2559.
99. Chavakis E, Hain A, Vinci M, et al. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circulation research 2007; 100: 204. (Pubitemid 46208720)
100. Lee SP, Youn SW, Cho HJ, et al. Integrin-linked kinase, a hypoxia-responsive molecule, controls postnatal vasculogenesis by recruitment of endothelial progenitor cells to ischemic tissue. Circulation 2006; 114: 150.
101. Satoh K, Fukumoto Y, Nakano M, et al. Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1. Cardiovascular research 2009; 81: 226.
102. Schroeter MR, Leifheit M, Sudholt P, et al. Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circulation research 2008; 103: 536.
103. Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells. Cardiovascular research 2008; 78: 413. (Pubitemid 351769775)
104. Urbich C, Heeschen C, Aicher A, et al. Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nature medicine 2005; 11: 206. (Pubitemid 40321357)
105. Basire A, Sabatier F, Ravet S, et al. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors. Thrombosis and haemostasis 2006; 95: 678.
106. Spiegel A, Shivtiel S, Kalinkovich A, et al. Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling. Nature immunology 2007; 8: 1123. (Pubitemid 47423760)
107. Urbich C, Dernbach E, Rossig L, Zeiher AM, Dimmeler S. High glucose reduces cathepsin L activity and impairs invasion of circulating progenitor cells. Journal of molecular and cellular cardiology 2008; 45: 429.
108. Oh J, Takahashi R, Kondo S, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 2001; 107: 789. (Pubitemid 34033671)
109. Vagima Y, Avigdor A, Goichberg P, et al. MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization. The Journal of clinical investigation 2009; 119: 492.
110. Cheng XW, Kuzuya M, Nakamura K, et al. Mechanisms underlying the impairment of ischemia-induced neovascularization in matrix metalloproteinase 2-deficient mice. Circulation research 2007; 100: 904. (Pubitemid 46555696)
111. Janowska-Wieczorek A, Marquez LA, Dobrowsky A, Ratajczak MZ, Cabuhat ML. Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Experimental hematology 2000; 28: 1274.
112. Rao Q, Zheng GG, Lin YM, Wu KF. Production of matrix metalloproteinase-9 by cord blood CD34+ cells and its role in migration. Annals of hematology 2004; 83: 409. (Pubitemid 38877960)
113. Zheng Y, Watanabe N, Nagamura-Inoue T, et al. Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential. Experimental hematology 2003; 31: 1237. (Pubitemid 37510029)
114. Xiang G, Schuster MD, Seki T, et al. Down-regulation of plasminogen activator inhibitor 1 expression promotes myocardial neovascularization by bone marrow progenitors. The Journal of experimental medicine 2004; 200: 1657. (Pubitemid 40094189)
115. Chade AR, Zhu X, Lavi R, et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 2009; 119: 547.
116. van Hinsbergh VWM, Engelse MA, Quax PHA. Pericellular proteases in angiogenesis and vasculogenesis. Arteriosclerosis, thrombosis, and vascular biology 2006; 26: 716.
117. van Beem RT, Verloop RE, Kleijer M, et al. Blood outgrowth endothelial cells from cord blood and peripheral blood: angiogenesis-related characteristics in vitro. J Thromb Haemost 200; 7: 217
118. Tanaka K, Sata M. Contribution of circulating vascular progenitors in lesion formation and vascular healing: lessons from animal models. Current opinion in lipidology 2008; 19: 498.
119. Yoder MC, Ingram DA. Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Current opinion in hematology 2009; 16: 269.
120. Ziegelhoeffer T, Fernandez B, Kostin S, et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circulation research 2004; 94: 230. (Pubitemid 38197456)
121. Schwartz RS. The politics and promise of stem-cell research. The New England journal of medicine 2006; 355: 1189.
122. Hruban RH, Long PP, Perlman EJ, et al. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. The American journal of pathology 1993; 142: 975.
123. Hilbe W, Dirnhofer S, Oberwasserlechner F, et al. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. Journal of clinical pathology 2004; 57: 965. (Pubitemid 39208249)
124. Murata H, Janin A, Leboeuf C, et al. Donor-derived cells and human graft-versus-host disease of the skin. Blood 2007; 109: 2663. (Pubitemid 46425918)
125. Mints M, Jansson M, Sadeghi B, et al. Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient. Human reproduction (Oxford, England) 2008; 23: 139. (Pubitemid 351767317)
126. Hove WR, van Hoek B, Bajema IM, Ringers J, van Krieken JH, Lagaaij EL. Extensive chimerism in liver transplants: vascular endothelium, bile duct epithelium, and hepatocytes. Liver Transpl 2003; 9: 552. (Pubitemid 36701689)
127. Simper D, Wang S, Deb A, et al. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation 2003; 108: 143. (Pubitemid 36871294)
128. Bittmann I, Hentrich M, Bise K, Kolb HJ, Lohrs U. Endothelial cells but not epithelial cells or cardiomyocytes are partially replaced by donor cells after allogeneic bone marrow and stem cell transplantation. Journal of hematotherapy & stem cell research 2003; 12: 359. (Pubitemid 36993425)
129. Minami E, Laflamme MA, Saffitz JE, Murry CE. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 2005; 112: 2951. (Pubitemid 41612297)
130. Hocht-Zeisberg E, Kahnert H, Guan K, et al. Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation. European heart journal 2004; 25: 749. (Pubitemid 38647935)
131. Sieveking DP, Buckle A, Celermajer DS, Ng MK. Strikingly different angiogenic properties of endothelial progenitor cell sub-populations: insights from a novel human angiogenesis assay. Journal of the American College of Cardiology 2008; 51: 660. (Pubitemid 351186872)
132. Ott I, Keller U, Knoedler M, et al. Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. Faseb J 2005; 19: 992. (Pubitemid 40827728)
133. Au P, Daheron LM, Duda DG, et al. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 2008; 111: 1302 (Pubitemid 351213415)
134. Loomans CJ, De Koning EJ, Staal FJ, Rabelink TJ, Zonneveld AJ. Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress? Antioxidants & redox signaling 2005; 7: 1468.